(Q52531351)

2 May 2018

title

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines. (English)

1 reference

2 May 2018

1 reference

Coulter A

1

1 reference

2 May 2018

Wong TY

2

1 reference

2 May 2018

Drane D

3

1 reference

2 May 2018

Bates J

4

1 reference

2 May 2018

Macfarlan R

5

1 reference

2 May 2018

Cox J

6

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

2 May 2018

published in

Vaccine

1 reference

2 May 2018

volume

16

1 reference

2 May 2018

issue

11-12

1 reference

2 May 2018

page(s)

1243-1253

1 reference

2 May 2018

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Direction of research on vaccination against influenza; new studies with immunologic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Use of adjuvants in studies on influenza immunization. III. Degree of persistence of antibody in human subjects two years after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

FOLLOW-UP STUDY ON ARMY PERSONNEL WHO RECEIVED ADJUVANT INFLUENZA VIRUS VACCINE 1951-1953

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Final Report on the Safety Assessment of Squalane and Squalene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980125-4

7 January 2021

10.1016/S0264-410X(98)80125-4

Identifiers

DOI

1 reference

2 May 2018

1 reference

2 May 2018